https://www.selleckchem.com/pr....oducts/cd38-inhibito
In individuals who underwent both chemotherapy and radiation therapy (XRT), the difference in time to XRT was no longer significant (P= 0.06. Recurrence time was 309 ± 263 and 212 ± 180 days in the HMO and county groups, respectively (P= 0.379). The time to death was 412 ± 285 and 343 ± 304 days for HMO and county models, respectively (P= 0.334). Our study demonstrates a statistically significant difference in time to adjuvant therapies between patients within a county hospital and a managed health care organization. This inf
Me gusta
Comentario
Compartir
